Literature DB >> 29607165

A quality improvement program with nutrition therapy: restriction of lipid emulsions in cardiac surgical patients.

Jian Gao1, Guo-Wei Tu2, Chun-Sheng Wang3, Du-Ming Zhu2, Lan Liu2, Hua Liu2, Xiao-Mei Yang2, Zhe Luo2.   

Abstract

BACKGROUND: To evaluate the effect of restriction of soybean-based intravenous fat emulsions (IVFEs) in clinical outcomes in cardiac surgical patients.
METHODS: This was a before-and-after interventional study comparing the clinical outcomes regarding the intervention of IVFEs restriction. Before August 2015, parenteral nutrition (PN) using a soy-based lipid emulsion was routinely implemented if patients failed to meet >60% of energy requirements in 48 h post cardiac surgery (Period A). Beginning in August 2015, a lipid restriction strategy was implemented in our cardiac surgery intensive care unit (CSICU) unless enteral route could not be established within 7 days (Period B). The ICU and hospital mortality, nosocomial infections during ICU stay, length of ICU and hospital stay, ICU and hospital cost, mechanical ventilation time and postoperative complications were compared between two periods.
RESULTS: A total of 761 patients (370 patients in Period A and 391 patients in Period B) were ultimately enrolled in this study. There were no significant differences in demographic characteristics and intraoperative and postoperative parameters between the two groups. After the implementation of IVFEs restriction, the overall ICU mortality and hospital mortality were similar between two groups. Nosocomial infection rate was significantly reduced (3.84% vs. 7.84%, P=0.021). The mean length of ICU stay (3.15 vs. 3.74 days, P<0.001) and hospital stay (12.14 vs. 13.24 days, P<0.001) were significantly lower. The mean in-hospital cost (133,368 vs. 139,383 Yuan, P=0.037) was found to be reduced after implementation of IVFEs restriction. The duration of mechanical ventilation was shorter in the latter period (35.23±10.43 vs. 47.63±12.54 hours, P=0.011). IVFEs restriction was also associated with reduced cholestasis (2.81% vs. 6.76%, P=0.013).
CONCLUSIONS: The implementation of soybean-based IVFEs restriction in cardiac surgical patients was associated with reduced postoperative nosocomial infection rate. It also led to reductions in the length of ICU/hospital stay, hospital costs and mechanical ventilation time and a lower incidence of cholestasis. Further studies are required to validate the conclusions.

Entities:  

Keywords:  Intravenous fat emulsions (IVFEs); nutrition therapy; parenteral nutrition (PN); quality improvement

Year:  2018        PMID: 29607165      PMCID: PMC5864690          DOI: 10.21037/jtd.2018.01.98

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  19 in total

1.  A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition.

Authors:  F D Battistella; J T Widergren; J T Anderson; J K Siepler; J C Weber; K MacColl
Journal:  J Trauma       Date:  1997-07

Review 2.  Nutrition in the critically ill patient.

Authors:  Kristine W A C Koekkoek; Arthur R H van Zanten
Journal:  Curr Opin Anaesthesiol       Date:  2017-04       Impact factor: 2.706

Review 3.  Parenteral Lipid Tolerance and Adverse Effects: Fat Chance for Trouble?

Authors:  Geert J A Wanten
Journal:  JPEN J Parenter Enteral Nutr       Date:  2015-07-15       Impact factor: 4.016

4.  The effects of different IV fat emulsions on clinical outcomes in critically ill patients.

Authors:  Christina E Edmunds; Rebecca A Brody; J Scott Parrott; Susan M Stankorb; Daren K Heyland
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

5.  Updates in Nutrition Support for Critically Ill Adult Patients.

Authors:  Diana Wells Mulherin; Sarah V Cogle
Journal:  Hosp Pharm       Date:  2017-01

6.  The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants.

Authors:  Sabrina E Sanchez; Lindsay P Braun; Laina D Mercer; Meredith Sherrill; Jennifer Stevens; Patrick J Javid
Journal:  J Pediatr Surg       Date:  2013-03       Impact factor: 2.545

Review 7.  Lipid emulsions for parenteral nutrition in critical illness.

Authors:  Julie Boisramé-Helms; Florence Toti; Michel Hasselmann; Ferhat Meziani
Journal:  Prog Lipid Res       Date:  2015-09-28       Impact factor: 16.195

Review 8.  Omega-3 polyunsaturated fatty acids in cardiac surgery patients: An updated systematic review and meta-analysis.

Authors:  Pascal L Langlois; Gil Hardy; William Manzanares
Journal:  Clin Nutr       Date:  2016-05-27       Impact factor: 7.324

9.  ESPEN Guidelines on Parenteral Nutrition: intensive care.

Authors:  Pierre Singer; Mette M Berger; Greet Van den Berghe; Gianni Biolo; Philip Calder; Alastair Forbes; Richard Griffiths; Georg Kreyman; Xavier Leverve; Claude Pichard
Journal:  Clin Nutr       Date:  2009-06-07       Impact factor: 7.324

10.  Current status of parenteral nutrition and enteral nutrition application: an assessment of nutritional prescriptions from 59 hospitals in the People's Republic of China.

Authors:  Gang Han; Zhenwei Yu; Ke Ma
Journal:  Ther Clin Risk Manag       Date:  2015-02-10       Impact factor: 2.423

View more
  1 in total

1.  Early Enteral Nutrition Tolerance in Patients With Cardiogenic Shock Requiring Mechanical Circulatory Support.

Authors:  Wen-Jun Liu; Jun Zhong; Jing-Chao Luo; Ji-Li Zheng; Jie-Fei Ma; Min-Jie Ju; Ying Su; Kai Liu; Guo-Wei Tu; Zhe Luo
Journal:  Front Med (Lausanne)       Date:  2021-12-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.